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Abstract
Identification of candidate causal variants in regions associated with risk of common dis-
eases is complicated by linkage disequilibrium (LD) and multiple association signals. None-
theless, accurate maps of these variants are needed, both to fully exploit detailed cell
specific chromatin annotation data to highlight disease causal mechanisms and cells, and
for design of the functional studies that will ultimately be required to confirm causal mecha-
nisms. We adapted a Bayesian evolutionary stochastic search algorithm to the fine mapping
problem, and demonstrated its improved performance over conventional stepwise and reg-
ularised regression through simulation studies. We then applied it to fine map the estab-
lished multiple sclerosis (MS) and type 1 diabetes (T1D) associations in the IL-2RA (CD25)
gene region. For T1D, both stepwise and stochastic search approaches identified four T1D
association signals, with the major effect tagged by the single nucleotide polymorphism,
rs12722496. In contrast, for MS, the stochastic search found two distinct competing models:
a single candidate causal variant, tagged by rs2104286 and reported previously using step-
wise analysis; and a more complex model with two association signals, one of which was
tagged by the major T1Dassociated rs12722496 and the other by rs56382813. There is low
to moderate LD between rs2104286 and both rs12722496 and rs56382813 (r2 ⋍ 0:3) and
our two SNP model could not be recovered through a forward stepwise search after condi-
tioning on rs2104286. Both signals in the two variant model for MS affect CD25 expression
on distinct subpopulations of CD4+ T cells, which are key cells in the autoimmune process.
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The results support a shared causal variant for T1D and MS. Our study illustrates the benefit
of using a purposely designed model search strategy for fine mapping and the advantage of
combining disease and protein expression data.
Author Summary
Genetic association studies have identified many DNA sequence variants that associate
with disease risk. By exploiting the known correlation that exists between neighbouring
variants in the genome, inference can be extended beyond those individual variants tested
to identify sets within which a causal variant is likely to reside. However, this correlation,
particularly in the presence of multiple disease causing variants in relative proximity,
makes disentangling the specific causal variants difficult. Statistical approaches to this fine
mapping problem have traditionally taken a stepwise search approach, beginning with the
most associated variant in a region, then iteratively attempting to find additional associat-
ed variants. We adapted a stochastic search approach that avoids this stepwise process and
is explicitly designed for dealing with highly correlated predictors to the fine mapping
problem. We showed in simulated data that it outperforms its stepwise counterpart and
other variable selection strategies such as the lasso. We applied our approach to under-
stand the association of two immune-mediated diseases to a region on chromosome
10p15. We identified a model for multiple sclerosis containing two variants, neither of
which was found through a stepwise search, and functionally linked both of these to the
neighbouring candidate gene, IL2RA, in independent data. Our approach can be used to
aid fine mapping of other disease-associated regions, which is critical for design of func-
tional follow-up studies required to understand the mechanisms through which genetic
variants influence disease.
Introduction
Genome-wide association studies have been very successful at identifying disease-associated
variation by exploiting linkage disequilibrium (LD), meaning that only a subset of markers
need be surveyed to detect association. However, this same LD, particularly when combined
with the presence of multiple disease causal variants in relative proximity, makes disentangling
the specific causal variants difficult. Mapping the likely causal variants in regions associated
with complex traits as precisely as possible is becoming increasingly important for two reasons.
Firstly, as detailed chromatin annotations become available, more precise maps of probable
causal variants will allow researchers to fully exploit these resources through integrative analy-
ses targeted at identifying the specific genes, molecules and cells underlying disease association
[1]. Secondly, the functional studies which are ultimately required to confirm causal mecha-
nisms are laborious and need to focus, from the outset, on the smallest yet most complete set of
plausible causal variants.
It is widely recognised that the most associated single nucleotide polymorphism (SNP) in a
region is not necessarily the causal variant [2], yet attempts at fine mapping disease signals typ-
ically proceed by successive conditioning on the most associated SNPs, a form of stepwise re-
gression that may produce incorrect results, particularly when causal variants are correlated,
i.e. in linkage disequilibrium (LD) [3]. Bayesian methods have been used for fine mapping
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association signals in dense and imputed genotyping data and generating credible sets of vari-
ants that are likely to contain the causal variant, analogous to credible intervals for odds ratios
[4]. However, these approaches typically make the simplifying assumption that exactly one
causal variant exists at any individual region [4] because accounting for multiple causal vari-
ants leads to exponential increase in the number of models that need to be considered with the
number of causal variants considered. Bayesian methods that summarise evidence across SNPs
in a region to assess either enrichment of signals in chromatin states [5] or colocalisation be-
tween association signals for different traits [6] make a similar single causal variant assump-
tion. As stepwise approaches often obtain evidence for additional, independent association
signals in a region [7–10], this assumption is unrealistic. One exception is BimBam [11] which
can fit multi SNP models, but considers all possible models up to a specified maximum number
of causal SNPs. As the number of potential models grows exponentially, BimBam is limited to
regions with relatively few SNPs for computational reasons.
Monte Carlo methods can avoid limitations on the number of causal variants by sampling
the model space rather than visiting all possible models. Here we adapt a Bayesian evolutionary
stochastic search algorithm, GUESS [12, 13], to the fine mapping problem. This method, and
its fast computational implementation, is tailored to efficiently explore the multimodal space
created by multiple SNP models. However, the very dense SNP map that is required for fine
mapping leads to extreme LD, which presents two specific challenges for GUESS. The first is
that SNPs in extremely tight LD can cause numerical instability in model fitting, so we use
minimal tagging to explore the model space and then expand all the tag models initially select-
ed by GUESS (Fig 1). Second, posterior support is diluted across SNPs in tight LD, potentially
preventing direct inference on the importance of individual SNPs. We therefore use posterior
model probabilities and patterns of LD to define sets of SNPs which have strong joint posterior
support for the hypothesis that one member of the set is causal for the trait. These are analo-
gous to the credible sets generated in the Bayesian fine mapping framework which assumes a
single causal variant per region [4], but allow for multiple causal variants.
Our adaptions around GUESS are available in an R package, GUESSFM (https://github.
com/chr1swallace/GUESSFM). We used GUESSFM to fine map the association of multiple
sclerosis (MS) and type 1 diabetes (T1D) to an established susceptibility region for immune-
mediated diseases on chromosome 10p15 (S1 Fig), which contains the candidate causal gene
IL2RA. IL2RA encodes a subunit CD25 (IL-2RA) of the interleukin 2 (IL-2) receptor that is es-
sential for the high affinity binding of IL-2 [14]. The region has provided some prime examples
of evolving genetic research. Initially associated with T1D susceptibility using a candidate gene
and tag SNP approach [15], further studies revealed association to other autoimmune diseases,
including MS [16] and rheumatoid arthritis [17], and demonstrated that multiple genetic
markers were needed to explain the T1D association [18]. Genotype to phenotype studies have
demonstrated that disease-associated variants in the region also associate with IL2RAmRNA
expression and CD25 protein expression on the surface of naive and memory CD4+ T cells
[19–21] and sensitivity of memory CD4+ T and activated T regulatory cells to IL-2 [22].
Results
The use of different genotyping panels for different diseases has presented a challenge for com-
parative analysis across diseases. Here, we refined the T1D and MS association signals in the as-
sociated region on chromosome 10p15 by taking advantage of a unified dense SNP map
provided by the ImmunoChip, a custom Illumina 200K Infinium High-Density array covering
186 distinct autoimmune susceptibility risk regions [7, 23]. We used genotypes on a total of
52,637 samples (S1 Table), and supplemented the ImmunoChip variants by imputation from
Bayesian Stochastic Search Approach to Fine Mapping
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Fig 1. Overview of the fine mapping tailored stochastic search strategy in GUESSFM. 1. SNPs are clustered based on genotype data. Tagging is used
to remove cases of extreme LD (r2 > 0.99) by selecting one SNP from each cluster (“tag set”), that which is in highest average r2 with all other SNPs. 2. All
possible models that can be formed from the tag SNPs may be considered by GUESS. Here, all seven possible models are considered but, in practice, with
larger numbers of tags than shown here, GUESS employs a stochastic search strategy to consider only a subset of models, prioritising those with greatest
statistical support. 3. GUESS selects the most likely models amongst those it has visited. Here, it selects two of the seven, but in larger data sets we retain
the 30,000 most likely. 4. Each of these selected models is expanded by considering all possible substitutions of tags by other members of their tag set. Each
expanded model is then assessed again individually, using an approximate Bayes factor [14].
doi:10.1371/journal.pgen.1005272.g001
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the 1000 Genomes Project data. This gave a total of 667 SNPs and small indels with minor al-
lele frequency> 0.005 in controls for analysis after genotype quality control.
To allow for the effects of LD, traditional conditional regression is often supplemented by
identifying subsets of SNPs with some minimum LD (e.g. r2> 0.8) with individual SNPs select-
ed by a forward stepwise procedure, within which it is suggested the causal variant may lie. We
compared our proposed approach to traditional conditional regression by simulating pheno-
types conditional on multiple “causal variants” selected randomly from within these genetic
data, and confirmed that the proposed approach both recovered a higher proportion of the
true effects and simultaneously detected fewer false positive results (Fig 2). GUESSFM requires
specification of the a priori expected number of causal variants in a region, nexp. We considered
either setting nexp = 3 or nexp = 5, and found the performance decreased when nexp was less
than the true value, but not when it was greater than the true value, suggesting that for recovery
of the correct causal variants it is better to set nexp higher rather than lower. We also considered
three regularised regression approaches: the lasso, the elastic net and the group lasso. The ROC
curves of those methods (for decreasing penalties) are intermediate to the stepwise and sto-
chastic GUESSFM search approaches (Fig 2). However, at traditional optimization thresholds
(minimising the ten fold cross validation), regularized regression approaches were extremely
anti-conservative, with a very high false discovery rate, compared to stepwise (stopping at
p< 10−8 or p< 10−6) or GUESSFM for suitable thresholds on posterior probabilities (S2
Table). Picking a regularisation parameter according to the number of predictors included
(three or five) produced a more competitive false discovery rate, but discovery rates were still
lower than with GUESSFM (S2 Table).
We applied our approach to the MS and T1D data sets. Posterior support for the number of
SNPs required to model the association is strongly peaked, favouring a two-SNP model in MS
and a four SNP model in T1D (S2 Fig). We summarised inference for SNPs over multiple mod-
els by considering the support for a SNP group according to the sum of posterior probabilities
(PP) over all models containing a SNP from that group. We term this the group marginal pos-
terior probability of inclusion (gMPPI), which can be understood as the probability that one
SNP in the group is causal for the trait of interest. For T1D, there is high confidence
(gMPPI> 0.8) for four SNP groups that we denote according to their order in S3 Fig: A (in-
dexed by rs12722496), C (rs11594656), E (rs6602437) and F (rs41295159). As the T1D data
have previously been analysed using stepwise regression [23], we compared our results to those
found by forward stepwise analysis of the same data (Table 1). We saw a direct correspondence
in terms of LD (r2> 0.6) between the SNPs identified by the two approaches (Table 2). Howev-
er, models found by GUESSFM had larger log likelihoods for a given number of SNPs, indicat-
ing that these models offered a better explanation of T1D-associated genetic variation in the
region.
In contrast, for MS, there were no SNP groups with high gMPPI. We instead saw two dis-
tinct models, which together accounted for> 80% of the posterior support amongst the
514,476 visited models: either model M1, consisting of SNP groups A (indexed by rs12722496)
and D (rs56382813), or model M2 consisting only of SNP group B (rs2104286). SNPs fromM1
and M2 were rarely selected together (total PP = 0.039 across the visited models). rs2104286
was reported as the single associated SNP in the region in the original MS ImmunoChip analy-
sis after forward stepwise regression [7] (Table 1). rs2104286 is in low to moderate LD with
both of the M1 index SNPs (r2’ 0.3, Table 3).
Haplotype analysis showed that whilst haplotypes carrying the rs2104286:C allele are pro-
tective for MS, so is a less common haplotype carrying the rs2104286:T allele and the protective
allele at rs56382813 (Table 4). Indeed, the addition of rs2104286 to a model consisting of the
haplotypes formed by M1 was non-significant (p = 0.196) whilst the addition of the haplotypes
Bayesian Stochastic Search Approach to Fine Mapping
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Fig 2. Comparison of of several multivariate methods for fine mapping using simulated data.We simulated quantitative phenotype data with between
two and five causal variants using genotype data from the T1D dataset for the IL2RA region. The simulated data sets were analysed using forward stepwise
regression, GUESSFM, the lasso, the group lasso and the elastic net. GUESSFM produces credible sets for each variant chosen using the snp.picker
algorithm described in Materials and Methods. We defined pseudo “credible sets” for the other approaches as the set of SNPs with r2 > 0.8 with a selected
SNP. We calculated the discovery rate (the proportion of causal variants within at least one credible set, y axis) and false discovery rate (proportion of
detected variants whose credible sets did not contain any causal variant, x axis) at different thresholds for the stepwise p value, the group marginal posterior
probability of inclusion (gMPPI) for GUESSFM and the regularization parameter(s) across simulated datasets (see Methods for details). GUESSFM-3 and
GUESSFM-5 refer to GUESSFM run with a prior expectation of three or five causal variants per region, respectively. Results are averaged over 1000
replicates.
doi:10.1371/journal.pgen.1005272.g002
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Table 1. Comparison of results from stochastic GUESSFM and stepwise searches. p values are shown for the stepwise search and compare the listed
model to the model above (or the null model, for single SNPs). Bayesian Information Criterion (BIC) is shown for stepwise models and index models found
through GUESSFM search.
Model p BIC
T1D Stepwise
rs61839660 < 2 × 10−16 -140.10
rs61839660+rs11594656 7.64 × 10−12 -177.61
rs61839660+rs11594656+rs12220852 1.40 × 10−9 -204.35
rs61839660+rs11594656+rs12220852+rs41295159 1.39 × 10−7 -218.83
T1D GUESSFM
rs12722496+rs11594656+rs6602437 – -207.00
rs12722496+rs11594656+rs6602437+rs41295159 – -234.95
MS Stepwise
rs2104286 < 2 × 10−16 -97.25
rs2104286+rs11256593 0.00001437106213 -105.85
MS GUESSFM
rs2104286 (“M2”) – -97.25
rs12722496+rs56382813 (“M1”) – -111.18
doi:10.1371/journal.pgen.1005272.t001
Table 2. LD (r2) between SNPs in selectedmodels for T1D using stochastic GUESSFM and stepwise searches. Each GUESSFM search signal has a
correspondng SNP found by conditional stepwise regression in moderate to strong LD.
GUESSFM Stepwise
rs61839660 rs11594656 rs12220852 rs41295159
rs12722496 0.88 0.02 0.02 0.00
rs11594656 0.02 1.00 0.26 0.02
rs6602437 0.05 0.25 0.62 0.01
rs41295159 0.00 0.02 0.00 1.00
doi:10.1371/journal.pgen.1005272.t002
Table 3. LD (r2) between SNPs in selectedmodels for MS using stochastic GUESSFM and stepwise
searches. For the preferred M1 model for MS, there is only weak to moderate LD between SNPs chosen by
GUESSFM and conditional approaches.
GUESSFM Stepwise
rs2104286 rs11256593
M2: rs2104286 1.00 0.33
M1: rs12722496 0.33 0.08
M1: rs56382813 0.31 0.29
doi:10.1371/journal.pgen.1005272.t003
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formed by the M1 SNPs to a model consisting of only rs2104286 was significant
(p = 2.64 × 10−6). However, the posterior support favours model M1 over M2 only by a factor
of 1.7 and this is dependent on our prior expectation for the number of causal variants: had we
expected only a single causal variant in the region, we would have favoured M2 by a factor of
1.7, with M1 being favoured only with a prior expectation of 1.8 or more causal variants (S4
Fig). Under any reasonable prior, the posterior support for the two models is so close that we
cannot choose between them on statistical evidence alone: we must consider them as plausible
alternative explanations for MS association in the region. Note that the M1 SNPs were not
within the credible set created under the single causal variant assumption, which consists of
rs2104286 alone [7].
We selected all high confidence SNP groups for more detailed exploration (Fig 3). The T1D
signals are located in (1) intron 1 of IL2RA—SNP group A, (2) intergenic between IL2RA and
RBM17—C, (3) 5’ of RBM17—E, and (4) 5’ of RBM17 to intron 2 of PFKFB3—F. Under the
model M1 for MS, SNP group A was also associated with MS, with the same alleles protective
for both (Table 5) whilst the second M1 signal (SNP group D) physically overlapped, but was
not in LD with, SNPs from group C. Under the model M2, the sole-MS associated SNP (B) is
located in intron 1 of IL2RA, neighbouring the T1D-associated SNP group A, but there was
only weak LD between A and B (r2 = 0.3).
Since we were unable to distinguish between the competing M1 and M2 models for MS
using SNP-disease association data alone, we sought corroborating evidence to support SNPs
in either model using CD25 flow cytometric expression data. The M2 SNP rs2104286 has been
associated with the age-dependent proportion of naïve T cells that express CD25 on their cell
surface and rs12722495 (within SNP group A, located in intron 1 of IL2RA) with the total ex-
pression of CD25 on memory T cells [19, 20]. rs12722495 has also been associated with IL2RA
mRNA expression in T cells, both resting [19] and activated by 48 hour culture with anti-CD3
+CD28 [21]. We selected a single tag SNP from each of the credible sets and examined which
could best explain CD25 protein expression phenotypes using previously published data from
179 samples [19], plus an additional 30 samples. Both phenotypes were best explained by a sin-
gle SNP: rs12722495 from group A again showed the strongest association with intensity of
CD25 expression on memory T cells (p = 5.50 × 10−10, S5 Fig). For the proportion of naive
CD4+ cells that express CD25, the M1 SNP rs41295055 from group D, whose association with
CD25 expression was not previously tested, was preferred to the M2 SNP rs2104286
(p = 3.45 × 10−8 versus p = 2.56 × 10−6, ΔBIC = 8.43, which is interpreted as “strong” evidence
in favour of rs41295055 [24]; Fig 4), supporting the hypothesis that rs2104286 is not itself func-
tional, but merely tags other functional variants which are causal for MS. The A and D SNP
groups coincide with regions in IL2RA that contain DNase I sensitivity sites indicating open
chromatin available to bind transcription factors under appropriate conditions (Fig 3). In
Table 4. Haplotype analysis of MS association using the index SNPs for the one and two SNPmodels selected.Minor alleles are indicated by bold
font. Fq = haplotype frequency.
rs12722496 rs56382813 rs2104286 Fq (%) OR CI–95% p
A G T 69.135 1.000 – –
A A C 15.053 0.804 0.769–0.840 < 2 × 10−16
G G C 9.996 0.823 0.781–0.868 4.66 × 10−13
A A T 5.594 0.854 0.797–0.915 8.06 × 10−06
doi:10.1371/journal.pgen.1005272.t004
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Fig 3. Six sets of SNPs can best explain the association of T1D and MS in the chromosome 10p15 region. LD: a heatmap indicating the r2 between
SNPs.Assoc: MPPI for MS and T1D the SNPs in a group, with total MPPI across a SNP group, gMPPI, indicated by the height of the shaded rectangle (see
Table 5 for numerical details). SNP groups are labelled by the letters A-F for reference. SNPs in this track are ordered by SNP group for ease of visualisation.
Genes: SNPs are mapped back to physical position and shown in relation to genes in the region.RNAseq: read counts in two pooled replicates of resting
Bayesian Stochastic Search Approach to Fine Mapping
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(“rest1” and “rest2”) and anti-CD3/CD28 stimulated (“stim1” and “stim2”) CD4+ T cells; y axes were truncated to allow visualization of intronic read counts.
Note the different limits for resting and stimulated cells, which show greater transcription of all protein coding genes in the region.DNase: DNase
hypersensitivity measured in CD4 cells by the Roadmap consortium. Replicate 1 (“rest1”) is RO_01689; replicate 2 (“rest2”) is RO_01736; y axes were
truncated again to improve visualization.
doi:10.1371/journal.pgen.1005272.g003
Table 5. SNPs selected by GUESSFMmapping of MS and T1D associations. SNP groups are labelled A-F for reference. Position is according to hg19;
MAF = minor allele frequency in UK controls, OR = odds ratio for minor allele, MPPI = marginal posterior probability of inclusion. SNP groups are divided by
horizontal lines, and the group MPPI (gMPPI) is the posterior probability of inclusion of any SNP in the group. We highlight in bold the SNP sets with some
support for association with either MS or T1D. The MSmodel “M1” consists of groups A and D, the model “M2” consists of group B.
MS T1D
Group SNP Position Alleles MAF Total MPPI MPPI OR Total MMPI MMPI OR
A rs12722563 6069561 G>A 0.107 0.544 0.019 0.858 1.000 0.000 1.000
rs12722522 6078553 G>A 0.098 0.059 0.848 0.000 0.636
rs12722508 6088743 A>T 0.098 0.134 0.845 0.012 0.644
rs7909519 6089841 T>G 0.098 0.000 1.000 0.037 0.641
rs61839660 6094697 C>T 0.089 0.002 0.860 0.005 0.619
rs12722496 6096667 A>G 0.099 0.139 0.845 0.645 0.626
rs12722495 6097283 T>C 0.099 0.163 0.844 0.300 0.628
rs41295049 6109676 G>A 0.087 0.003 0.855 0.001 0.617
B rs2104286 6099045 T>C 0.262 0.408 0.408 0.839 0.000 0.000 0.929
C rs11597367 6107534 A>G 0.239 0.000 0.000 1.040 0.859 0.259 0.769
rs35285258 6118770 C>T 0.237 0.000 1.039 0.214 0.769
rs11594656 6122009 T>A 0.237 0.000 1.038 0.386 0.767
D rs3118475 6107265 T>C 0.191 0.628 0.040 0.811 0.000 0.000 0.941
rs62626317 6110925 A>G 0.191 0.102 0.807 0.000 0.938
rs41295055 6111622 C>T 0.191 0.075 0.808 0.000 0.937
rs41295079 6119154 C>T 0.190 0.053 0.809 0.000 0.942
rs62626325 6121285 G>A 0.176 0.082 0.808 0.000 0.907
rs41295105 6122674 T>G 0.190 0.033 0.812 0.000 0.942
rs56382813 6124262 G>A 0.207 0.242 0.825 0.000 0.907
E rs6602437 6130077 T>C 0.433 0.000 0.000 1.018 0.956 0.956 1.187
F rs41295121 6129643 C>T 0.009 0.000 0.000 1.000 0.857 0.082 0.541
rs41295159 6148535 C>G 0.009 0.000 0.937 0.083 0.541
rs80250062 6191884 T>C 0.008 0.000 0.941 0.063 0.540
rs78938174 6193815 T>C 0.009 0.000 0.941 0.063 0.540
rs142414821 6194739 G>A 0.008 0.000 0.941 0.063 0.540
rs189193613 6197361 G>C 0.009 0.000 0.941 0.063 0.540
rs74765647 6197496 G>A 0.007 0.000 0.941 0.063 0.540
rs146135969 6200643 A>T 0.008 0.000 0.941 0.063 0.540
rs117678801 6201774 C>T 0.008 0.000 0.941 0.063 0.540
rs78815004 6210827 G>A 0.008 0.000 0.941 0.063 0.540
rs189961326 6213265 G>A 0.008 0.000 0.941 0.063 0.540
rs76585197 6214560 G>A 0.007 0.000 0.941 0.063 0.540
rs75252425 6217022 G>A 0.008 0.000 0.941 0.063 0.540
doi:10.1371/journal.pgen.1005272.t005
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addition, the existence of RNA-seq reads from resting and stimulated CD4+ T cells within in-
tron 1, where group A SNPs lie (Fig 3), support the regulatory nature of this region [25].
Discussion
The 10p15 region contains at least five apparently distinct associations to the immune-mediat-
ed diseases, T1D and MS. Our results are the first to support a four SNP model in T1D, which
most likely reflects a combination of increased sample sizes and the increased variant density
available due to ImmunoChip and imputation, as this model was supported by both stepwise
regression and GUESSFM. A previous comparative study of MS and T1D susceptibility in this
region using conditional analysis of tag SNPs identified three groups of SNPs [26]: their group
I matches our group A, their group II our group C, and their group III our group B. The results
showed that the minor allele of SNPs in all these groups was protective for T1D, but that group
I (A) was not associated with MS and that group II (C) was susceptible for MS. Our results,
based on larger sample sizes and more extensive variant coverage, suggest that the minor allele
of SNPs in group A, shared between T1D and MS, are associated with the same protective effect
for both diseases. This emphasises the need for surveying the most complete set of variants pos-
sible in order to make cross disease comparisons.
Variants in this region have previously been linked to several aspects of IL-2R signalling in
T1D and MS patients [27] and the MS-associated variants we identify (whether under the M1
Fig 4. The proportion of naive CD4+ T cells that express CD25 (log scale) increases with age. The MS protective allele for the M2 SNP rs41295055:
C > T associates with fewer CD4+ T cells expressing CD25 across all ages (p = 3.45 × 10−8), and is statistically preferred to the previously reported M1 SNP,
rs2104286:T > C (p = 2.56 × 10−6; Δ BIC = 8.43). S and P are used to represent the (common) MS-susceptible and (rare) MS-protective alleles respectively at
each SNP. These SNPs are in limited LD (r2 = 0.3).
doi:10.1371/journal.pgen.1005272.g004
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or M2 models) all showed some evidence of association with expression of CD25 on the surface
of T cells, linking IL2RA in a primary way into the etiology of this disease. For T1D, we were
only able to link the IL2RA intron 1 signal, shared with MS under the M1 model, to CD25 ex-
pression on memory T cells. Neither the intergenic T1D SNP group (C), despite physical over-
lap with the MS associated SNP group D, indexed by rs41295055, nor the sets near RBM17 and
PFKFB3 (E and F) have yet been linked to IL2RA expression. These signals could relate to
CD25 expression on other cell subsets or under specific conditions. The cell-specific regulation
of IL2RA expression and its role in modulating the immune system are both complex and only
partially understood. For example, in addition to T cells, IL2RA is also expressed on many
other cell types, especially under inflammatory conditions [28]. We have data on only a subset
of IL-2R phenotypes that have been previously reported, and previous studies have genotyped
only a subset of the disease associated SNPs described in this paper. Further genotyping of
large samples with IL-2R related phenotypes is warranted to properly assess any other potential
effects of the disease signals we identify on IL-2R signalling. Alternatively, it may be that other
genes in the region, which have not been as well studied as IL2RA, are also causal for T1D, ei-
ther directly or through interaction with IL2RA. For example, PFKFB3, an inducible 6-phos-
phofructo-2-kinase/fructose-2, 6-bisphosphatase isoform, allows rapid responses to energy
requirements and insufficiency can lead to apoptosis and an inability to undergo autophagy in
CD4+ T cells in RA [29]. PFKFB3 has also been implicated in regulating insulin secretion in
pancreatic beta cells [30], which could explain the T1D specific signals across this gene. All
three genes, IL2RA, PFKFB3 and RBM17 are upregulated in CD4+ T cells upon ex vivo activa-
tion (S3 Table) and two candidate SNPs, from groups E and F, sit between two DNase I sites
close to the RBM17 promoter. Furthermore, gene regulation can extend over 100 kb [31] and
further studies will be needed to confirm the gene(s) through which these other SNPs influence
T1D risk.
Two or more independent signals are commonly observed in fine mapped autoimmune dis-
ease regions using stepwise regression [7–10]. Despite long established doubts regarding the
validity of stepwise regression [3], its use has continued to dominate in GWAS because of the
number of SNPs measured simultaneously. Stepwise regression addresses the questions: ‘which
is the single variant that can best explain the maximum trait variance?’ and, conditional on this
single variant, ‘do any other variants explain additional trait variance?’ This is not equivalent to
asking what set of variants best jointly explain trait variance. Often, as we have observed for
T1D, stepwise regression may be expected to identify the same signals as a stochastic search ap-
proach. However, our analyses demonstrate that different results may be produced by stepwise
and full multi-variant search approaches in some cases. In particular, we highlight and prefer a
two SNP model for MS association to the IL2RA region, one of the SNPs shared with T1D
(group A, indexed by rs12722495) and associated with CD25 expression on memory T cells,
the other (group D, indexed by rs41295055) a better predictor for CD25 expression on the sur-
face of naive CD4+ T cells than the SNP identified by stepwise regression (group C, rs2104286).
Methods that search the multimodal model space formed by multiple SNPs without condi-
tioning on univarate association signals can therefore reveal a more accurate picture of the like-
ly disease causal variants in any region. Other Bayesian [32], stochastic search [33] and
penalised regression approaches such as lasso [34, 35] have been proposed on a GWAS scale,
but these aim primarily to detect association in data sets with relatively sparse genotype cover-
age. Our focus is the adaptation of a Bayesian variable selection method to the fine mapping
problem, and it is likely that an alternative method, such as piMASS [36], could have been
substituted for GUESS in the model selection step. A detailed and direct comparison of
piMASS with GUESS showed a similar recovery of models in simulated data, but indicated that
GUESS was more computationally efficient [13]. We chose to use GUESS for its computation
Bayesian Stochastic Search Approach to Fine Mapping
PLOS Genetics | DOI:10.1371/journal.pgen.1005272 June 24, 2015 12 / 22
efficiency, but also because its g-prior formulation is specifically designed to deal with highly
correlated predictors, a beneficial feature for fine mapping.
Applying the regularised regression approaches to our simulated data showed that the ROC
curve for lasso with decreasing penalty out-performed stepwise analysis, but optimising the
regularization parameter by minimising the cross validation error led to very high false discov-
ery rates, suggesting that in this context this criterion is highly anti-conservative. Previous stud-
ies have also indicated that while regularised regression has strengths in terms of prediction, it
may have weaknesses in terms of model selection [37], particularly for correlated predictors
[38]. Elastic net [39] and the group lasso [40] have been proposed as regularised approaches
tailored to correlated predictors, but in our hands did not outperform the simple lasso plus
construction of a set of plausible SNPs according to r2> 0.8. We considered that the informa-
tion supplied to GUESSFM as a prior expected number of causal variants could be included
equivalently in a regularised approach by setting the regularisation parameter according to the
number of predictors selected. Although this produced a more competitive false discovery rate,
discovery rates remained lower than with GUESSFM (S2 Table).
Our multidimensional analysis strategy, tailored to the high genotyping coverage (and,
hence, high LD) required for fine mapping causal variants can provide a more complete picture
of the likely causal variants in a region. Any fine mapping study is limited by the set of variants
included for study. While we attempted to survey the fullest possible set of SNPs and small
indels by using dense genotyping data, plus imputation to the 1000 Genomes Project data, we
cannot be sure we included all variants that might affect gene function without sequencing of
cases and controls [41]. Further, larger indels, VNTRs and microsatellites remain particularly
difficult to genotype with accuracy yet may contribute to disease. Therefore, it is important to
bear in mind that all claims that a particular variant is causal are conditional on the true causal
variants being accurately genotyped and included in the study.
It is well known that functional biological interactions may exist between variants [42], and
therefore the possibility of statistical interactions needs to be considered in fine mapping stud-
ies. However, the need to fit interaction terms depends on the evolutionary history of the re-
gion. In the IL2RA region, there has been very little historical recombination (S1 Fig) and D0
between markers is nearly always 1, also indicating a lack of recombination [43]. As a conse-
quence, only three of the possible four haplotypes that may be formed from any pair of SNPs
are observed, and statistical interaction parameters are inestimable. This also implies that there
is a one to one transformation between a haplotype model and a model expressing the log odds
of disease as a linear function of single SNP effects [44], as we have employed. Thus, for the
IL2RA region, we may neglect statistical interactions without making any assumptions about
the existence of biological interactions. For our method to be applied to regions in which D0 <
1, it would need extension to include statistical interaction terms. One simple approach, if the
number of SNPs is not to large, would be to generate additional variables representing interac-
tions between SNPs with D0 < 1, but extending GUESS to fit interaction terms is another direc-
tion for further research.
An alternative approach would be to attempt to study disease risk across haplotypes directly
[45], although these need to be inferred probabilistically when recombination has occurred.
Haplotype-based analysis has become less common as marker density has increased. One rea-
son for this is that haplotypes are particularly useful when marker density is low, because a
haplotype may tag a causal variant better than any single variant, and haplotype studies have
thus fallen out of fashion as denser genotype data have become available. This is exemplified by
a study that found multiple statistical interactions underlying gene expression [46] (statistical
interactions may be thought of as haplotype models) using SNPs on a genomewide array. Sub-
sequent analysis found that all interactions which replicated in an external dataset with whole
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genome sequencing, and thus with more complete coverage of potential causal variants, could
be better explained by a single SNP [47]. This suggests, perhaps, that statistical interactions be-
tween SNPs will prove rare. However, if biological interactions between variants separated by
LD do exist, and the interaction depends on the phase of the variants, i.e., the diplotype risk dif-
fers from the two locus genotype risk, haplotype methods will again be required to infer likely
causal variants.
One way to understand the means through which the effects of a disease-associated variant
are mediated is to perform functional assays to examine its effects on a gene’s function [48] or
to identify potentially intermediate phenotypes with which it is also associated [19]. Improved
identification of likely causal variants should lead to more powerful and reliable follow-up
studies, an important factor when many of these experiments require fresh primary cells and
laborious wet lab protocols. Similarly, comparison with summary results from eQTL studies
would be facilitated by the application of multi modal search strategies to the eQTL data set to
ensure the effects of genetic variation are mapped as accurately as possible [49]. Even with
large samples, and careful fine-mapping analyses, the causal candidacy of SNPs in high LD can-
not be resolved through statistical association alone. Functional studies designed to directly ad-
dress the confounding induced by linkage disequilibrium, such as allele-specific expression
using rare haplotypes that distinguish SNPs in the same tag group, may be helpful in refining
further the likely causal variants.
Informative approaches to understanding disease etiology have recently been developed
based on looking for enrichment of the cell-specific chromatin marks localising to likely causal
variants, and these are being used to highlight disease relevant cells [23, 50]. Here, again, more
accurate identification of causal variants will lead to more powerful and precise comparisons,
and our approach, which is associated to a more accurate estimation of posterior probabilities
for the SNPs in the considered region, should be readily adaptable to the growing set of meth-
ods that aim to examine enrichment [5] or colocalisation [6] by model averaging over the pos-
terior probabilities that a SNP is causal.
Materials and Methods
Definition of target region
For fine mapping, we require dense coverage of genetic polymorphisms in the region. We tar-
geted the ImmunoChip fine mapping region centred on IL2RA, namely chr10:6030000-
6220000 (hg19). This region is bounded by recombination hot spots (S1 Fig).
Genotype data
Genotype data for this region comes from the MS [7] and the T1D [23] ImmunoChip studies.
Quality control measures were applied to SNPs and samples as previously described [7]. As MS
samples were derived from multiple international cohorts and we found allele frequencies for
SNPs in the region varied between cohorts, we manually inspected plots of the first five princi-
pal components formed from ancestry informative markers [7] and additionally excluded sam-
ples lying outside the main cluster in each cohort.
Imputation
We used IMPUTE2 [51] to impute untyped SNPs using the 1000 Genomes Phase I reference
panel. We included a 500 kb window either side of our target region to allow variants in the
less densely genotyped neighbouring regions to contribute information on the untyped SNPs.
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Adapted “shotgun”GUESS analysis
Tagging. Although GUESS is designed to work with correlated variables, the extreme, and
occasionally perfect, LD in very dense genotyping data can lead to unstable results. We found,
through a process of trial and error, that tagging so that no two SNPs remained with r2> 0.99
retained good convergence of the stochastic GUESS algorithm. This reduced the number of
SNPs from 667 to 443 (T1D) and 453 (MS). For each SNP that was removed, we noted its
index SNP, the remaining SNP which had the highest r2 with it. We call a set of SNPs sharing a
single index SNP a tagset; the number and size of tagsets is shown in S6 Fig.
GUESS analysis. We ran GUESS in parallel on each disease using the index SNPs defined
above. For MS, which included internationally derived samples, we included country of origin
as a categorical covariate. Monitoring plots for each GUESS run, generated by R2GUESS [52]
(http://cran.r-project.org/web/packages/R2GUESS), are shown in S7 and S8 Figs. We saved the
top 30,000 models visited for each disease and for each saved model, we generated an expanded
set of models, by adding each model that could be formed by replacing any index SNP with any
of the SNP(s) in its tagset (Fig 1). This expanded the set of models under consideration,M, ten
fold, to 514,476. For each trait, we derived a posterior weight for each model inM. To be pre-
cise, we generated approximate Bayes factors for each model,m 2M, for each trait, using the
Bayesian Information Criterion (BIC) approximation:
BICm ¼ 2 log ðBFmÞ
where
BICm ¼ 2ðlog ðLmÞ  log ðL0ÞÞ þ ðkm  k0Þ log ðnÞ;
Lm and km represent the logistic likelihood of the data and the number of parameters under
modelm, n is the number of samples and 0 represents the null model. Finally we combined
these Bayes factors with priors for each model, πm, to derive a posterior probability for each
model
PPm / BFmpm:
Choice of priors
Priors could conceivably be generated on the basis of individual SNP content, for example, to
prioritise those overlapping genomic annotations of particular interest. Such an approach has
been adopted in a hierarchical framework, albeit with the single causal variant assumption [5].
For simplicity, and because we were interested to discover likely causal variants without prede-
fining their likely mechanism, our model priors were determined only by the number of SNPs
contained in a model, Nm. A natural prior is then binomial or beta binomial. Given that, for a
fixed expected value, a beta binomial puts larger weight on implausibly large models, we chose
to use a binomial model, and, given published data on T1D, set the expected number of SNPs
at three. For N SNPs in the target region, this means the prior for a model containing Nm SNPs
is
pm ¼
N
Nm
 
qnð1 qÞNNm
where q is set so the expected value of the binomial distribution was 3, ie q ¼ 3
N
.
Priors and posteriors for the number of causal SNPs are shown in S2 Fig.
SNP groups for candidate causal variants. We do not expect that we will be able to dis-
criminate, statistically, between highly correlated variants. Instead, the posterior support is
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likely to be diluted across such sets of variants. To group such SNPs, we used the marginal pos-
terior probabilities of inclusion (MPPI) for each SNP, and applied the following algorithm:
1. Pick the index SNP with maximumMPPI
2. Order remaining SNPs by decreasing r2 with index SNP
3. Exclude SNPs which co-occur in models with the index SNP (joint MPPI> 0.02)
4. Step away from the index SNP in order of decreasing r2, adding SNPs to its group until
MPPI< 0.001 for two SNPs in a row (NB, these SNPs will not be added to the SNP group),
or until r2< 0.5
5. Remove this set of SNPs and return to step 1 until no SNP remains with MPPI> 0.01.
We summarize the support for any group of SNPs by the gMPPI, the sum of the posterior
probabilities over all models containing a SNP in that group. The complete algorithm is avail-
able in the function snp.picker from the R package GUESSFM (https://github.com/
chr1swallace/GUESSFM).
Model averaged effect estimates. We produced effect estimates for each SNP i as
bi ¼
X
m2M
Iði 2 mÞbðmÞi PðmÞ
where bðmÞi is the estimated effect of SNP i in modelm, I(i 2m) is an indicator function taking
the value 1 if SNP i is included in modelm, and 0 otherwise, and P(m) is the posterior probabil-
ity ofm 2M.
Simulation analysis
We used simulated data to compare the performance of our proposed method, traditional step-
wise regression, the lasso [53] and the elastic net [39]. For each simulation, we selected a ran-
dom subset of 2,000 T1D control samples genotyped in the IL2RA region and a random set of
between two and five “causal variants” from amongst the SNPs with MAF> 0.01. We simulat-
ed a Gaussian phenotype for which the causal variants acted in an additive manner to jointly
explain 10% of the phenotypic variance. We conducted a total of 1,000 simulations for each
scenario.
The data were analysed in parallel using the four different methods. We performed forward
stepwise regression, and selected index SNPs at a given p value threshold, α, as those SNPs se-
lected at any stage of the stepwise process with p< α. For each index SNP, we created pseudo
“credible sets” as the set of SNPs with r2 > 0.8 with the selected index SNPs. Note, by this defi-
nition, simulated causal SNPs may appear in more than one SNP group. We calculated the
false discovery rate as the proportion of SNP groups which did not contain a causal variant,
and we calculated the discovery rate as the proportion of causal variants found in at least one
selected SNP group.
We used the snp.picker function from GUESSFM (http://github.com/chr1swallace/
GUESSFM) with default settings to define credible sets for causal SNPs. By definition of the al-
gorithm, SNPs may only be members of at most one SNP group. We selected SNP groups ac-
cording to varying thresholds for the gMPPI, and calculated false discovery and discovery rates
as above.
For lasso and elastic net, we used the R package glmnet [54], and optimised the regularisa-
tion parameter λ by minimising the ten fold cross validation error using the cv.glmnet()
function. For elastic net, we kept the folds constant across different values of α 2 [0.1,1] and
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chose the pair of values (α, λ) which minimised the ten fold cross validation error overall. To
examine the path of elastic net solutions, we fixed α at this value and varied λ. We used the R
package gglasso [55] to implement the grouped lasso, predefining groups of variables as
those with r2> 0.8 with each other using heirarchical clustering. We also considered the dis-
covery and false discovery rates with the first three or first five predictors selected, as something
analagous to the prior information given to GUESSFM about our expectation of the number of
causal variants.
Association with cell surface expression of CD25
Naive CD4+ T cells from 209 donors were gated as previously described [19, 56]. Association
with index SNPs from disease-associated groups was assessed through linear regression. All
possible one, two and three SNP models were considered, and the model with the minimum
BIC reported. Expression was log transformed to reduce right skew of the phenotype.
DNase hypersensitivity data
We downloaded DNase I hypersensitivity for CD4+ T cells from the Roadmap Consortium
[57] from http://vizhub.wustl.edu/VizHub/hg19, accessed 19 September.
RNA seq gene expression data
Wemeasured gene expression in the studied region in two pooled samples (n = 3 and n = 4 in-
dividuals / pool) comparing unstimulated and stimulated CD4+ T cells. For each individual,
250,000 CD4+ T cells (93–99% pure, RosetteSep Human CD4+ T Cell Enrichment Cocktail,
StemCell Technologies) were stimulated with anti-CD3/CD28 T-activator beads (Dynabeads
Life Technologies) at a ratio of 0.3 beads / cell for four hours at 37°C in X-VIVO-15 (Lonza)
+ 1% AB serum (Lonza) and penicillin/ streptomycin (Life Technologies). Unstimulated CD4+
T cells were cultured in medium alone for four hours. Cells were harvested directly into Qiagen
lysis buffer (Qiagen) and stored at -80°C until RNA isolation.
RNA was isolated using RNeasy micro kit including gDNA depletion (Qiagen). RNA integ-
rity and concentration was evaluated using the Bioanalyzer platform (Agilent), with all samples
showing an RNA integrity score (RIN)> 9.8. 750 ng of total RNA were used for the prepara-
tion of cDNA libraries using the Illumina TruSeq (Illumina) platform with a low-cycle-number
PCR protocol, and was followed by transcriptome sequencing on an Illumina HiSeq 2000. This
yielded four libraries with* 38 million 100 bp paired-end reads each.
We trimmed raw reads to remove primer and adapter contamination, which affected 2% of
our sequences, using HTSeq [58]. Reads were aligned to the reference genome Ensembl
GRCh37.p13 using STAR [59]. Removal of low quality and unpaired reads, indexing, IL2RA re-
gion extraction, and depth counting were performed using SAMtools [60]. We employed
HTSeq and DESeq2 [61] to carry out a differential expression analysis between the two condi-
tions based on normalised read counts. We only considered paired-end reads that featured a
total and unambiguous overlap with genomic sequence assigned to genes, around 73% of the
initial raw sequences. Mapped read counts at each position in each sample are in S4 Table.
This study was approved by local Institutional Review Boards (IRBs) and written informed
consents were obtained from all participants in the study. For JDRF/Wellcome Trust Diabetes
and Inflammation Laboratory the IRBs are: NRES Committee East of England—Cambridge
Central (ref: 08/H0308/153), statistical analysis; and NRES Committee East of England—Nor-
folk (ref: 05/Q0106/20), for gene expression work. This study was approved by the University
of Virginia Institutional Review Board (IRB number 17457); the Type 1 Diabetes Genetics
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Consortium collection sites obtained approvals for all subject collections and written consent
and/or assent was obtained from all participants or their surrogates in the study.
Supporting Information
S1 Fig. Manhattan plots for MS and T1D on chromosome 10:6,000,000-6,300,000 (hg19).
Bottom track shows HapMap recombination rates and the blue bar indicates the region tar-
geted for fine mapping.
(TIFF)
S2 Fig. Prior and posterior probabilities across number of SNPs in underlying candidate
causal models. For posteriors, this is the sum of posterior probabilities over all models visited
by GUESS which contain the number of SNPs shown.
(TIFF)
S3 Fig. Patterns of inclusion of SNP groups in T1D andMS. Total filled bar height is propor-
tional to gMPPI for the group indexed by the SNP shown on the x axis. Only the most probable
SNP groups (gMPPI> 0.1) are labelled; “other” denotes SNPs outside these more probable
SNP groups. Black fill indicates high confidence SNP groups (A-F) that were taken forward for
further analysis. Groups indexed by rs17173494 and rs11256593 were considered to have too
little support for either disease for association to be declared with confidence. For MS, we see
two competing models: M1 indexed by A (rs12722496) and D (rs56382813), and M2, indexed
by B (rs2104286).
(TIFF)
S4 Fig. Sensitivity analysis showing the effect of varying the prior expectation of the num-
ber of causal variants on the relative posterior support for model M1 over M2 for MS. The
relative posterior support is calculated as the posterior probability of all models within the M1
group divided by the posterior probability of all models within the M2 group for a given prior
expectation. For a prior expectation of three, this is the ratio of bar heights for M1 over M2
from S4 Fig.
(TIFF)
S5 Fig. Normalised mean fluorescence intensity of CD25 dye on memory CD4+ T cells in-
creases with copies of the (minor) T1D-protective (P) allele at rs12722495:T> C compared
to the susceptible (S) allele, p = 5.50 × 10−10.
(TIFF)
S6 Fig. Size of SNP groups after tagging at r2> 0.99.
(TIFF)
S7 Fig. GUESS monitoring plots for T1D. The three chains are indicated by different colours.
(TIFF)
S8 Fig. GUESS monitoring plots for MS. The three chains are indicated by different colours.
(TIFF)
S1 Table. Samples with ImmunoChip genotyping data used in the fine mapping analysis.
(PDF)
S2 Table. Discovery and false discovery rates in simulated data using different model selec-
tion methods and specified optimisation criteria, as described in Methods. Briefly, we ran
GUESSFM setting the mean expected number of causal variants per region to either three
(GUESSFM-3) or five (GUESSFM-5). We calculated the discovery rate (the proportion of
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causal variants within at least one credible set, y axis) and false discovery rate (proportion of
detected variants whose credible sets did not contain any causal variant, x axis) at different
thresholds for the stepwise p value (< 10−6 or< 10−8), the group marginal posterior probability
of inclusion (gMPPI> 0.5 or> 0.9) for GUESSFM and the regularization parameter λ (chosen
to minimise the ten-fold cross validation error, or at the largest value that selected exactly three
or five predictors) across simulated datasets.
(PDF)
S3 Table. Differential expression analysis of genes in the region considered in this paper.
All genes with measurable expression (reads> 20) in the studied samples are shown. Normal-
ized read counts are shown for the two replicates of resting and stimulated CD4+ T cells.
(PDF)
S4 Table. Mapped read counts in each sample in the target region from four RNA seq sam-
ples, as described in Methods.
(GZ)
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